| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc8b706fb22ca0baba35f66ce3e501ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7bd39bce7029b09696666bf91e35111e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-402
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-06 |
| filingDate |
2010-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2016-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81df6deecfaf189a39576ce2373fa82b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12f06a5859e5913ad33e855c9221f0ad
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_08c06ba984c816e1bde82ec8175add58 |
| publicationDate |
2016-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2569123-T3 |
| titleOfInvention |
Slow infusion of sulcardin and its salts |
| abstract |
Composition composed of an active ingredient which is 4-methoxy-N- (3,5-bis- (1-pyrrolidinyl) -4-hydroxybenzyl) -benzenesulfonamide or a pharmaceutically acceptable salt thereof for use in the treatment of arrhythmia which comprises administering to a subject said composition composed of an active ingredient which is 4-methoxy-N- (3,5-bis- (1-pyrrolidinyl) -4-hydroxybenzyl) -benzenesulfonamide or a pharmaceutically acceptable salt thereof, comprising the administration intravenously administering said composition substantially uniformly to said subject, in which no more than about 0.5 mg / kg of said active substance is administered to said subject per minute, in which said subject suffers or is at risk of having a cardiac arrhythmia. |
| priorityDate |
2009-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |